Brady W. Dougan - 15 Sep 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role: Director, 10%+ Owner
Signature: /s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Issuer symbol: HUMA
Transactions as of: 15 Sep 2022
Net transactions value: -$6,090,000
Form type: 4
Filing time: 19 Sep 2022, 16:34:45 UTC
Previous filing: 13 Jun 2022
Next filing: 12 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUMA	Common Stock	Sale	$6,090,000	-1,522,500	-7.4%	$4.00	18,930,004	15 Sep 2022	By Ayabudge LLC	F1
holding	HUMA	Common Stock						510,161	15 Sep 2022	Direct
holding	HUMA	Common Stock						1,158,240	15 Sep 2022	By spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale was made by Ayabudge LLC, an entity controlled by Brady W Dougan, in a block trade. The purchaser is an existing investor of the Issuer, who had previously participated in the Issuer's PIPE financing transaction, and was interested in increasing its ownership of the Humacyte, Inc. The transaction enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchaser to acquire a large block of shares at a time that Humacyte, Inc. was not conducting a financing and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

Content

The sale was made by Ayabudge LLC, an entity controlled by Brady W Dougan, in a block trade. The purchaser is an existing investor of the Issuer, who had previously participated in the Issuer's PIPE financing transaction, and was interested in increasing its ownership of the Humacyte, Inc. The transaction enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchaser to acquire a large block of shares at a time that Humacyte, Inc. was not conducting a financing and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.